cryptotreasury

1. BIOTECH FIRM TO TRANSFORM INTO CRYPTO TREASURY ENTITY
2. NEW COMPANY TO HOLD $583M IN HYPE TOKENS + $305M CASH
Nasdaq-listed Sonnet BioTherapeutics is set to merge with Rorschach I LLC, shifting its core focus from biotechnology to crypto treasury management under the new name Hyperliquid Strategies Inc. (HSI).
Key Details:
Valuation: $888 million
HYPE Token Holdings: 12.6M tokens (~$583M)Cash Reserves: $305MTicker: New Nasdaq symbol post-mergerInvestors: Paradigm, Galaxy Digital, Pantera, Republic, D1 Capital, 683 CapitalHSI will lead crypto treasury operations using Hyperliquid’s Layer-1 blockchain, with $HYPE as its central asset. Some biotech programs like SON-1010 will continue under retained operations
.Leadership Changes:
Chairman: Bob Diamond (Atlas Merchant Capital)
CEO: David Schamis (Atlas CIO)Board Additions: Eric Rosengren (ex-Boston Fed), Sonnet independentsPrivate Placement & Funding:
$5.5M raised via convertible preferred stock & warrants
$2M in convertible notes to convert into equityProceeds to support biotech and deal expensesOwnership Post-Merger:
Rorschach & New Investors: 98.8%
Sonnet Stakeholders: 1.2%Market Outlook: A bold pivot from biotech to blockchain—positioning HSI as a major crypto asset manager on Nasdaq.
#CryptoMerger ##USCryptoWeek #SonnetBio #Hyperliquid #CryptoTreasury

IVD Medical Holdings, a publicly traded healthcare firm in Hong Kong, has added $19 million worth of Ether $ETH (ETH) to its corporate treasury — but it’s not just for holding.

The company plans to use ETH as the core infrastructure asset for its tokenization platform, ivd.xyz, aimed at transforming how pharmaceutical intellectual property and other healthcare assets are managed on-chain.

🧬 ETH at the Heart of Healthcare Tokenization

According to IVD’s Chief Strategy Officer Gary Deng, Ethereum was chosen because it’s the:

“World’s most mature smart contract platform”

Highly liquid

Gaining growing institutional approval, including a spot ETH ETF in the U.S.

Here’s what ETH will be used for:

Ownership confirmation of tokenized assets

Automated revenue distribution

Compliance governance

Backing for IVDD stablecoin

Settlement layer for cross-border healthcare transactions

💰 Beyond HODLing: Staking, Derivatives, and Yield

IVD plans to actively deploy ETH into:

Staking and re-staking

On-chain derivatives

Yield strategies to boost returns while maintaining liquidity and downside protection

This strategy aligns IVD with a growing trend of Hong Kong-listed firms allocating treasury to crypto — but with a more utility-driven approach compared to passive BTC $BTC holdings.

🤝 Strategic Partnership with HashKey

The move follows a partnership with HashKey Group, one of the few licensed crypto platforms in Hong Kong. HashKey will likely play a key role in enabling compliant infrastructure for ETH-backed healthcare finance solutions.

📈 A Growing List of HK Crypto Treasuries

IVD joins a small but growing club of Hong Kong-listed crypto treasuries:

Boyaa Interactive holds over 3,100 BTC

Meitu previously bought 31,000 ETH and 940 BTC

Smaller holders include Yuxing, Moon Inc., and Walnut Capital

But unlike others, IVD is using ETH not just as an asset — but as a foundation for innovation in healthcare tokenization.

Will tokenized real-world assets (RWAs) become the next big crypto use case?

#Ethereum #Tokenization #IVDMedical #CryptoTreasury #HealthcareBlockchain

IVD Medical Holdings, a Hong Kong–listed healthcare company, has made a $19 million purchase of Ether$ETH (ETH) to anchor its blockchain-based tokenization strategy.

The ETH acquisition will serve as the backbone for ivd.xyz, IVD’s upcoming platform designed to tokenize pharmaceutical intellectual property and other healthcare assets. The company says Ethereum will power ownership verification, automated revenue distribution, and compliance governance for these tokenized assets.

Why Ethereum?

Chief Strategy Officer Gary Deng explained that Ethereum was selected because it is:

The world’s most mature smart contract platform

Highly liquid and widely adopted

Increasingly recognized by institutions, especially after the U.S. SEC approved a spot ETH ETF

ETH will also be the settlement layer for IVD’s planned IVDD stablecoin, enabling compliant cross-border transactions between Hong Kong and the U.S.

Active Treasury Management

Unlike companies that simply hold crypto, IVD plans to deploy its ETH holdings for:

Staking and re-staking

On-chain derivatives trading

Yield strategies that boost returns while maintaining liquidity and downside protection

This active approach aims to strengthen IVD’s treasury performance while supporting its blockchain infrastructure.

Partnership With HashKey Group

IVD’s ETH move coincides with a partnership with HashKey Group, one of Hong Kong’s licensed crypto exchanges. The partnership is expected to provide the regulated infrastructure needed for IVD’s tokenized asset ecosystem.

Part of a Growing Trend in Hong Kong

IVD joins a select group of Hong Kong–listed companies holding crypto:

Boyaa Interactive: Over 3,100 BTC $BTC (~$300M)

Meitu: Formerly held 31,000 ETH and 940 BTC

Smaller holders include Yuxing InfoTech, Moon Inc., and Walnut Capital

However, IVD is among the first to integrate ETH directly into real-world asset (RWA) tokenization rather than holding it purely for investment.

The Bigger Picture

Tokenizing real-world assets has become a hot sector in crypto, with Ethereum leading the way for compliance-friendly on-chain infrastructure. IVD’s move suggests that healthcare tokenization could become a significant use case for blockchain — one that combines financial efficiency with industry-specific innovation.

#Ethereum #Tokenization #CryptoTreasury #HealthcareBlockchain #RWA